Skip to main content

RT @AurelieRheumo: BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ,

Social Author Name
Aurelie Najm
Tweet Content
BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ, 50% ADA PASI 100 65% PBO/BKZ, 61% BKZ, 48% ADA No Rx progression 87% PBO/BKZ, 89% BKZ, 94% ADA Candida infections 7% BKZ, 0.7% ADA https://t.co/MMjN1Aa3qf Abs#L02 #ACR22 @Rheumnow https://t.co/keF0QOZMwA
Show on Archive Page
On
Display in Search Results
On
PDQ
Off